- $1.62bn
- $1.36bn
- €1.44bn
- 90
- 57
- 51
- 72
Annual income statement for SGHC, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 476 | 908 | 1,321 | 1,292 | 1,436 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 486 | 748 | 1,106 | 1,334 | 1,397 |
Operating Profit | -10 | 160 | 215 | -41.6 | 39.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -17.6 | 150 | 226 | 217 | 16.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17.9 | 149 | 236 | 182 | -8.61 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -17.9 | 149 | 236 | 181 | -10.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -17.9 | 149 | 236 | 181 | -10.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.097 | 0.233 | 0.392 | 0.588 | 0.025 |
Dividends per Share |